Form 8-K - Current report:
SEC Accession No. 0001564590-20-026867
Filing Date
2020-05-26
Accepted
2020-05-26 16:13:29
Documents
2
Period of Report
2020-05-21
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rcus-8k_20200521.htm 8-K 41202
2 EX-3.1 rcus-ex31_7.htm EX-3.1 299484
  Complete submission text file 0001564590-20-026867.txt   342070
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 20910608
SIC: 2834 Pharmaceutical Preparations